SkyQuest Technology Group recently introduced Point-of-care Glucose Testing Market study with in-depth overview, describing about the Product/Industry Scope and elaborates market outlook and status (2025-2032). The market Study is segmented by key regions which is accelerating the marketization. The Point-of-care Glucose Testing Market has witnessed Excellent growth over the past decade and is expected to maintain its upward trajectory.
Point-of-care Glucose Testing Market size was valued at USD 3.44 Billion in 2023 and is poised to grow from USD 3.58 Billion in 2024 to USD 4.98 Billion by 2032, growing at a CAGR of 4.2% during the forecast period (2025-2032).
The Point-of-care Glucose Testing Market is witnessing notable growth due to increasing demand across various industries and advancements in technology. Factors such as rising consumer awareness, evolving regulations, and the push for sustainable and innovative solutions are driving market expansion. Additionally, the adoption of Point-of-care Glucose Testing Market is fueled by its versatile applications and growing focus on efficiency, quality, and performance.
Get a Free Sample PDF of the Report – https://www.skyquestt.com/sample-request/point-of-care-glucose-testing-market
The 2025 global Point-of-care Glucose Testing Market report provides a comprehensive analysis of key industry players, market trends, pricing structures, and competitive dynamics, offering insights into the market landscape from 2025 to 2032. As a rapidly evolving sector, the Point-of-care Glucose Testing Market drives economic growth, innovation, and technological advancements through the development, production, and distribution of products and services. This report highlights the market’s growth potential and its impact on global industries, providing valuable insights for stakeholders, investors, and policymakers.
Detailed Segmentation and Classification of the report (Market Size and Forecast – 2032, Y-o-Y growth rate, and CAGR):
The Point-of-care Glucose Testing Market can be segmented based on several factors, including product type, application, end-user, and distribution channel.
Type
Lancing Devices And Strips, Blood-Glucose Meter
Application
Type-1 Diabetes, Type-2 Diabetes
End User
Hospitals and Clinics, Home Care Settings, Others
Point-of-care Glucose Testing Market – Regional Analysis:
– Point-of-care Glucose Testing North America Market includes (Canada, Mexico, USA)
– Point-of-care Glucose Testing Europe Market includes (Germany, France, Great Britain, Italy, Spain, Russia)
– Point-of-care Glucose Testing Asia-Pacific Market includes (China, Japan, India, South Korea, Australia)
– Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa)
– Point-of-care Glucose Testing South America Market includes (Brazil, Argentina)
– Point-of-care Glucose Testing Oceania Market (Australia & New Zealand)
Top Market Players in Point-of-care Glucose Testing Market are:
Abbott Laboratories (USA)
Roche Holding AG (Switzerland)
Ascensia Diabetes Care Holdings AG (Switzerland)
Dexcom, Inc. (USA)
Medtronic plc (Ireland)
LifeScan, Inc. (USA)
Becton, Dickinson and Company (BD) (USA)
ACON Laboratories, Inc. (USA)
Nova Biomedical Corporation (USA)
ARKRAY, Inc. (Japan)
Trividia Health, Inc. (USA)
PTS Diagnostics (USA)
Nipro Corporation (Japan)
Ypsomed Holding AG (Switzerland)
Sanofi S.A. (France)
EKF Diagnostics Holdings plc (UK)
Prodigy Diabetes Care, LLC (USA)
Bayer AG (Germany)
Danaher Corporation (USA)
Platinum Equity Advisors, LLC (USA)
Point-of-care Glucose Testing Key Market Trends:
Integration with Digital Health Platforms: The integration of point-of-care glucose testing devices with digital health platforms and electronic health records is a significant trend in 2022. This integration enables seamless data transfer, analysis, and real-time monitoring of glucose levels. It empowers patients to actively participate in their diabetes management and allows healthcare professionals to make informed treatment decisions based on comprehensive patient data.
Focus on Remote Patient Monitoring: Remote patient monitoring using point-of-care glucose testing devices is gaining traction. With advancements in telehealth and remote healthcare services, patients can perform glucose tests at home and share the results with healthcare providers. This trend promotes patient convenience, reduces the need for in-person visits, and enhances disease management, especially during the COVID-19 pandemic.
Also Read –
https://www.openpr.com/news/3827779/artificial-lift-systems-market-strategic-roadmap-to-revenue
https://www.newstrail.com/silicon-carbide-market-breakthrough-innovations-and-trends-2025-2032/
Forward-Looking Insights
The Point-of-care Glucose Testing Market is set to experience sustained growth, fueled by technological advancements, broader global market access, and rising industry demand. With the industry addressing emerging challenges and capitalizing on new opportunities, it is expected to drive innovation and play a pivotal role in advancing global health and economic progress.
About Company:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact Details:
SkyQuest Technology Group
USA (+1) 351-333-4748
Email: [email protected]
